Pet Medication Innovation Watch

MGA® and Experior™ and Monovet® and Tylovet® (melengestrol acetate Type A medicated article) and (lubabegron Type A medicated article) and (monensin Type A medicated article) and

MGA® and Experior™ and Monovet® and Tylovet® (melengestrol acetate Type A medicated article) and (lubabegron Type A medicated article) and (monensin Type A medicated article) and / tylosin phosphate Type A medicated article

Recently FDA-confirmed FDA-confirmed FDA-confirmed

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.

Veterinary professional?

What this means

Owner summary

This is a public veterinary medicine update Roxee is tracking with source-backed evidence and availability labels.

Do not start, stop, or switch medicine without your veterinarian.
Development-stage products are not shown as available unless FDA approval or marketed evidence is public.
Ask your veterinarian about currently approved options for fda-confirmed approval.

Vet view

Technical note

No vet-facing summary has been approved for this innovation record yet.

Regulator: FDA/CVM
Pathway: NADA/ANADA/CNADA
FDA application: 200808

Regulatory timeline

Public stage evidence

Only supported or current stages are highlighted.

1 Early research signal
2 Company-disclosed development
3 FDA-CVM development path disclosed
4 Protocol concurrence disclosed
5 Pivotal study planned
6 Pivotal study recruiting
7 Pivotal study completed
8 Technical section submitted
9 Technical section complete
10 All major technical sections complete
11 Administrative NADA/CNADA submitted
12 FDA approved
13 Conditionally approved
14 Available / marketed

What changed

Latest public update

Date detected: May 19, 2026
Stage: FDA approved
Reason: MIW source adapter refresh

Owner-safe interpretation

Availability

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.

Expected availability: FDA approved, launch unclear

Evidence

Source-backed record

1 item shown

Source: FDA Recent Animal Drug Approvals
Observed: May 19, 2026
Supports: FDA approved

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii , and for reduction of incidence of liver ab...

View source evidence